Bicarbonate

Bicarbonate

SCHEMBL5025536

CC(=N)N(C)C.O=C(O)O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.40
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
TSHR P16473 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
THPO P40225 2/20 0.35
NFKB1 P19838 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 1/20 0.35
APEX1 P27695 1/20 0.35
PMP22 Q01453 1/20 0.35
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL408921 0.84
Succinic Acid SCHEMBL27634156 0.82 LMNA (0.52) FFAR3TSHRNFKB1PMP22LMNA
Hydrochloric Acid SCHEMBL10519592 0.81
Bromide SCHEMBL14994188 0.81
Bicarbonate SCHEMBL455147 0.79 ALDH1A1 (0.39) FFAR3LCKFYNTSHRALDH1A1
Bicarbonate SCHEMBL28245040 0.77 FFAR3 (0.46) FFAR3LCKFYNTSHRALDH1A1
Bicarbonate SCHEMBL28901039 0.76 ALDH1A1 (0.37) TSHRALDH1A1CA1CA2CA9
Bicarbonate SCHEMBL15574952 0.76 LMNA (0.39) TSHRALDH1A1CA1CA2CA9
Acetic Acid SCHEMBL4152430 0.76 FFAR3 (0.47) FFAR3LCKFYNTSHRALDH1A1
Trimethylammonium SCHEMBL28443711 0.71 CA1 (0.56) FFAR3LCKFYNTSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943266-A2 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS Amira Pharmaceuticals, Inc. (US) 2008-07-16 EP claimed
WO-2007056228-A2 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (GB) 2007-05-18 WO claimed
EP-1957434-A1 REVERSIBLY SWITCHABLE SURFACTANTS AND METHODS OF USE THEREOF QUEEN'S UNIVERSITY AT KINGSTON (CA) 2008-08-20 EP disclosed
WO-2007056859-A1 REVERSIBLY SWITCHABLE SURFACTANTS AND METHODS OF USE THEREOF QUEEN'S UNIVERSITY AT KINGSTON (CA) 2007-05-24 WO disclosed